Psychopharmacologic Management of Patients with Borderline Personality Disorder
- 1 June 1988
- journal article
- review article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 33 (5) , 355-359
- https://doi.org/10.1177/070674378803300508
Abstract
This paper reviews recent literature on the psychopharmacologic management of borderline personality disorder (BPD) patients and discusses an approach to drug therapy. Five randomized controlled trials have shown positive, but non-specific effects of antipsychotic drugs on the symptoms suffered by BPD patients. There were too few data on other types of drugs to draw any conclusion. We propose that BPD patients be treated on the basis of being in a state or episode of co-existing Axis I disorder.Keywords
This publication has 15 references indexed in Scilit:
- A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neurolepticsPsychoneuroendocrinology, 1984
- Self-Destructive Behavior in a Patient Taking TrazodoneAmerican Journal of Psychiatry, 1984
- Response of borderline and schizotypal patients to small doses of thiothixene and haloperidolAmerican Journal of Psychiatry, 1984
- The positive effect of alprazolam in the treatment of three patients with borderline personality disorderAmerican Journal of Psychiatry, 1984
- Drug therapy in borderline patientsComprehensive Psychiatry, 1984
- Hysteroid dysphoria: an unsuccessful attempt to demonstrate its syndromal validityAmerican Journal of Psychiatry, 1982
- Levodopa in Borderline DisordersArchives of General Psychiatry, 1982
- Pharmacotherapy of borderline disordersComprehensive Psychiatry, 1981
- Low-Dose Neuroleptic Regimens in the Treatment of Borderline PatientsArchives of General Psychiatry, 1979
- COMPARATIVE CHEMOTHERAPEUTIC TRIAL IN TREATMENT OF CHRONIC BORDERLINE PATIENTSAmerican Journal of Psychiatry, 1964